Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Form PRER14A: Revised preliminary proxy statement

Deciphera Pharmaceuticals, Inc. Form PRER14A: Revised preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-04-22: Form PRER14A; Description PRER14A; Document dcph-20240422.htm.
FiledFormPeriod of reportDescriptionDocument
2024-04-22PRER14APRER14Adcph-20240422.htm